Stock Analysis of Biora Therapeutics Inc (BIOR) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code BIOR
Close 0.715
Change -0.0229 / 3.10 %
Volume 328005
Vol Change 94755.00 / 40.62 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Biora Therapeutics Inc
PE (TTM)

-39.85

Very Poor
Price / Book

-44.43

Very Poor
Price / Sales

2432560

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

25656.92 K

Enterprise Value

56157.92 K

ROA (TTM)

-305.14

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

-6104350.00

Very Poor
Revenue

94.10 %

18000.00
Net Profit

220.84 %

-122424.00 K
Debt to Equity

-0.451

Very Poor
Altman Z Score

-56.03

Very Poor
Quick Ratio

0

Poor
Cash Ratio

0.242

Poor


Highs/Lows of Biora Therapeutics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.7161 0.154 % 2.32 % 0.760.681210-May-2414-May-24
Two Week0.642 11.37 % 5.77 % 0.76980.63106-May-2402-May-24
One Month0.62 15.32 % 4.87 % 0.76980.58506-May-2418-Apr-24
Three Month0.809 11.62 % 5.54 % 1.990.58528-Feb-2418-Apr-24
Six Months1.34 46.64 % 17.88 % 1.990.58528-Feb-2418-Apr-24
One year3.35 78.66 % 28.33 % 6.69960.58509-Jun-2318-Apr-24
Two year18.625 96.16 % 31.92 % 13.4250.58527-Sep-2218-Apr-24


Technical View of Biora Therapeutics Inc
RSI

47.03

Neutral
MACD

-0.0162

Bullish
ADX

17.58

Bearish
Super Trend

0.789

Mild Bearish
Williams %R

-32.62

Mild Bearish
CCI

62.21

Neutral


EMA 5

0.728

Bearish
EMA 15

0.714

Bullish
EMA 50

0.813

Mild Bearish
EMA 100

1.04

Mild Bearish
SMA 100

0.965

Mild Bearish
SMA 200

1.57

Strong Bearish
SMA 5 / 20

0.735 / 0.678

Bullish
SMA 15 / 50

0.699 / 0.853

Mild Bearish
SMA 50 / 200

0.853 / 1.57

Mild Bearish




Charts of Biora Therapeutics Inc


Returns of Biora Therapeutics Inc with Peers
Period / StockBIORBCTXUBXMTCR
1 Week-0.154%-27.23%-6.13%2.18%
1 Mth15.32%-29.74%2.00%2.43%
3 Mth-11.62%-49.54%-23.12%2.41%
6mth-46.64%-62.95%-16.39%39.42%
1 Year-78.66%-75.19%-46.69%23.70%
2 Year-96.16%-67.00%-81.11%-85.36%
5 Years-2658.04%-98.35%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Biora Therapeutics Inc with Peers
Ratio / StockBIORBCTXUBXMTCR
PE-39.85-6.30-168.07-0.644
P/B-44.43-7.80139.320.536
ROA-305.14-17.01-40.07-58.14
ROE00-82.90-83.21
Debt To Equity-0.45100.1220.246
Revenue18000.00
94.10 % 		0
% 		0
100.00 % 		0
%
Net Income-122424.00 K
220.84 % 		-20302.39 K
24.35 % 		-52531.00 K
87558.32 % 		-62207.00 K
66.76 %


Technicals of Biora Therapeutics Inc with Peers
Technical / StockBIORBCTXUBXMTCR-
ADX17.5825.1517.2714.32
CMF0.0360-0.464-0.2650.565
MFI69.8422.3763.9986.62
RSI47.0325.6545.4857.12
MACD Abv SignalTrueFalseFalseTrue
Price Above 50 MAFalseFalseFalseTrue-
Price Above 200 MAFalseFalseFalseTrue-


About : Biora Therapeutics Inc

Address : 4330 La Jolla Village Drive, San Diego, CA, United States, 92122
Tel : 833 727 2841
URL : https://www.bioratherapeutics.com
Code : BIOR, ISIN : US74319F1075, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 19_Jun_2020
Employee Count : 58

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)